This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Clear Cell Renal Cell Carcinoma

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Clear Cell Renal Cell Carcinoma Means

Clear cell renal cell carcinoma (ccRCC) is a type of kidney cancer that starts in the cells lining tiny tubes inside the kidney. These tubes help filter blood by returning nutrients and fluids the body needs back into circulation. When doctors look at these cancer cells under a microscope, they appear clear or very pale, which is why the cancer is named “clear cell.” It is the most common type of kidney cancer in adults, accounting for about 80% of cases.

Why This Cancer Type Matters in Care

Knowing that a kidney cancer is ccRCC helps doctors decide the best way to diagnose, treat, and monitor the disease. This cancer can behave differently from other kidney cancers, so treatment plans are often tailored to it. Treatments may include surgery to remove part or all of the kidney, immunotherapy to help the immune system fight cancer, targeted drugs that focus on specific changes in cancer cells, and sometimes radiation or local treatments that destroy tumor cells with heat or freezing.

What Patients Might Experience and See

People with ccRCC may notice symptoms such as blood in the urine, pain in the side or back, unexplained weight loss, fever, or feeling very tired. However, many people have no symptoms, and the cancer is found during imaging tests like CT scans or MRIs done for other reasons. To confirm the diagnosis, doctors often perform a biopsy, where a small sample of the tumor is taken and examined under a microscope. Imaging tests also help doctors understand the size of the tumor and whether the cancer has spread.

Where You Might Hear or See the Term ccRCC

The term ccRCC may appear in medical reports, treatment plans, visit notes, or when discussing clinical trials and drug options. It is one of several names for this cancer, including clear cell renal cell carcinoma and conventional renal cell carcinoma. Understanding this term can help you ask informed questions and better understand your care.

What the Term Does Not Automatically Mean

Having ccRCC does not automatically mean the cancer has spread or how aggressive it is. Each person’s situation is unique, and doctors consider many factors like tumor size, location, and overall health when planning care. The name describes the cancer’s appearance under a microscope but does not predict the exact course of the disease.

Questions to Ask Your Care Team

If you or a loved one has ccRCC, it can help to ask your healthcare team questions such as: What stage is my cancer? Has it spread? What treatment options are best for me? Are there clinical trials I can join? How will treatment affect my kidney function? These questions can guide discussions and help you understand your care plan.

Understanding Family Risk and Genetic Links

Some cases of ccRCC run in families, especially in people with von Hippel-Lindau syndrome, a genetic condition caused by changes in the VHL gene. This syndrome increases the risk of developing ccRCC and other tumors. If you have a family history of kidney cancer or related conditions, your doctor might suggest genetic counseling or testing.

Important Reminder About This Information

This information is meant to help you understand clear cell renal cell carcinoma but cannot replace personalized medical advice. Always discuss your diagnosis, treatment options, and prognosis with your doctor, who can provide guidance tailored to your unique health needs.

Next Steps After Learning About ccRCC

If you or a loved one has been diagnosed with ccRCC, the next step is to learn about your specific case and work closely with your healthcare team to decide on the best care plan. Understanding this cancer type can help you feel more confident asking questions and making decisions about your treatment and follow-up care.

Sources

Public source information used for this glossary entry includes: